| 1 |
32176647 | Oxidized Products of Omega-6 and Omega-3 Long Chain Fatty Acids Are Associated with Increased White Matter Hyperintensity and Poorer Executive Function Performance in a Cohort of Cognitively Normal Hypertensive Older Adults. | 2020 |
3 |
| 2 |
32182938 | Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma. | 2020 Mar 9 |
2 |
| 3 |
32192153 | Soluble Epoxide Hydrolase 2 Expression Is Elevated in Obese Humans and Decreased by Physical Activity. | 2020 Mar 17 |
1 |
| 4 |
29960002 | Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner. | 2018 Sep 15 |
2 |
| 5 |
30031209 | Neuroprotective effects of epoxyeicosatrienoic acids. | 2018 Sep |
2 |
| 6 |
25824304 | Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa. | 2016 Apr |
4 |
| 7 |
26621325 | Soluble epoxide hydrolase: A potential target for metabolic diseases. | 2016 May |
2 |
| 8 |
27079253 | 11,12-Epoxyecosatrienoic acids mitigate endothelial dysfunction associated with estrogen loss and aging: Role of membrane depolarization. | 2016 May |
2 |
| 9 |
25330284 | Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis. | 2015 May 10 |
2 |
| 10 |
26453326 | Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration. | 2015 Dec 1 |
2 |
| 11 |
25173047 | Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans. | 2014 Oct |
1 |
| 12 |
22303912 | Soluble epoxide hydrolase inhibitors and cardiovascular diseases. | 2013 Jan |
2 |
| 13 |
23701967 | Soluble epoxide hydrolase: gene structure, expression and deletion. | 2013 Sep 10 |
2 |
| 14 |
22116511 | Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease. | 2012 Feb 1 |
2 |
| 15 |
22298653 | Epoxides and soluble epoxide hydrolase in cardiovascular physiology. | 2012 Jan |
2 |
| 16 |
21825980 | Cytochrome P450-dependent eicosanoid production and crosstalk. | 2011 Oct |
1 |
| 17 |
20339956 | Development of a high throughput cell-based assay for soluble epoxide hydrolase using BacMam technology. | 2010 Jul |
1 |
| 18 |
20425256 | Soluble epoxide hydrolase in atherosclerosis. | 2010 May |
2 |
| 19 |
20531214 | Targeting epoxides for organ damage in hypertension. | 2010 Oct |
2 |
| 20 |
19794443 | Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. | 2009 Oct |
2 |
| 21 |
16961727 | Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors. | 2006 Summer |
3 |
| 22 |
18221075 | Soluble epoxide hydrolase: a novel target for the treatment of hypertension. | 2006 Jan |
2 |
| 23 |
10775319 | Toxicity of epoxy fatty acids and related compounds to cells expressing human soluble epoxide hydrolase. | 2000 Apr |
1 |
| 24 |
10775430 | Metabolism of monoepoxides of methyl linoleate: bioactivation and detoxification. | 2000 Apr 15 |
2 |